Effect of various oral dose levels of a trimethoprim/sulphadiazine mixture on Bordetella bronchiseptica infection and on the proliferation of trimethoprim-resistant faecal coliforms in pigs
- 31 January 1983
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 90 (1) , 41-47
- https://doi.org/10.1017/s0022172400063816
Abstract
When a 1:5 mixture of trimethoprim (TMP) and sulphadiazine was fed to pigs intra-nasally infected with Bordetella bronchiseptica, 10 mg/kg/day was shown to be highly effective in suppressing the organism. This dose level had little effect on numbers of TMP-resistant coliforms in faeces, but oral doses of 30 mg/kg/day eventually selected a resistant population. It is suggested that the proliferation of resistant coliforms would be minimized by administration of the lowest oral dose rates of antibacterial drugs compatible with efficacy.This publication has 5 references indexed in Scilit:
- Escherichia coli resistant to tetracyclines and to other antibiotics in the faeces of U.K. chickens and pigs in 1980Epidemiology and Infection, 1981
- Treatment of experimental Bordetella bronchiseptica infection in young pigs with potentiated sulphonamide in the drinking waterVeterinary Record, 1981
- Canine bordetellosis: chemotherapy using a sulphadiazine-trimethoprim combinationVeterinary Record, 1979
- Animal Model for Determining the No-Effect Level of an Antimicrobial Drug on Drug Resistance in the Lactose-Fermenting Enteric FloraAntimicrobial Agents and Chemotherapy, 1975
- Trimethoprim Resistance Conferred by W Plasmids in EnterobacteriaceaeJournal of General Microbiology, 1972